Polarean Imaging PLC (LON:POLX) chief executive Richard Hullihen dropped into the Proactive studio as the medtech firm kicked off its first day of trading on AIM.
The company raised gross proceeds of ?3mln via the placing of 20mln ordinary shares at a price of 15p - representing 27.3% of the company's share capital.
Hullihen says the point of coming to the market was specifically to raise the cash for their upcoming Phase III trials for their drug-device technology.
Meet ANGLE plc, Faron Pharmaceuticals Ltd, Alliance Pharma plc, Clinigen Group PLC and Avacta Group Plc at our event,London, 05 April 2018.Register here >>